( Reuters) – The U.S. Department of Health and Human Being Services (HHS) said on Saturday it would enable state health departments to disperse Gilead Sciences Inc’s remdesivir drug to eliminate COVID-19, and the United States would get about 40%of the drug maker’s international contribution.
FILE PICTURE: Vials of investigational coronavirus illness (COVID-19) treatment drug remdesivir are topped at a Gilead Sciences facility in La Verne, California, U.S. March 18,2020 Gilead Sciences Inc/Handout via REUTERS/File Photo
Gilead has actually devoted to supply approximately 607,000 vials of remdesivir over the next six weeks in the United States, and the U.S. state health department will distribute the dosages to proper hospitals in their states, HHS said.
Gilead’s drug has actually shown promise in helping clients infected with COVID-19, the disease caus